Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein.

AIM--To determine whether aP2 expression is a useful diagnostic marker in soft tissue tumour pathology. METHODS--A polyclonal antibody to aP2 was used to investigate the immunohistochemical expression of this protein in benign and malignant tumours of adipocytic differentiation and a wide variety of other neoplasms. RESULTS--aP2 was only expressed by lipoblasts (in all types of liposarcoma and in lipoblastomatosis) and by brown fat cells (in both hibernomas and normal periadrenal fetal fat). Other benign adipose tissue tumours and malignant connective tissue or epithelial tumours were distinguished from liposarcoma by the absence of staining for aP2. CONCLUSION--Identification of lipoblasts using markers of aP2 expression is of value in the differential diagnosis of benign and malignant adipose tissue tumours and in distinguishing liposarcomas from other malignant mesenchymal and epithelial neoplasms, some of which contain cells that morphologically resemble lipoblasts.

[1]  C. Fletcher,et al.  Soft Tissue Tumors , 1995, Current Topics in Pathology.

[2]  Johannes Gerdes,et al.  Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections , 1993, The Journal of pathology.

[3]  B. Spiegelman,et al.  Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. , 1993, The Journal of biological chemistry.

[4]  C. Devlin,et al.  Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. , 1992, Journal of cell science.

[5]  C. Dani,et al.  Growth and differentiation of regional adipose tissue: molecular and hormonal mechanisms. , 1991, International journal of obesity.

[6]  F. Watt Cell culture models of differentiation , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  P. Houghton,et al.  Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. , 1990, The American journal of pathology.

[8]  A. Smith,et al.  Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. , 1989, Biochemistry.

[9]  A. Burdi,et al.  Growth and development of adipose tissue. , 1988, The Journal of pediatrics.

[10]  J. Aubin,et al.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.

[11]  T. Doering,et al.  Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. , 1985, Biochemical and biophysical research communications.

[12]  D. Bernlohr,et al.  Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Salm,et al.  Pleomorphic lipoma: a tumour simulating liposarcoma , 1983, Histopathology.

[14]  T. Nakajima,et al.  An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues , 1982, The American journal of surgical pathology.

[15]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[16]  B. Shmookler,et al.  Pleomorphic lipoma: A benign tumor simulating liposarcoma. A clinicopathologic analysis of 48 cases , 1981, Cancer.